2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin D...

Organic compounds -- part of the class 532-570 series – Organic compounds – 9,10-seco-cyclopentanohydrophenanthrene ring system or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S167000, C549S200000

Reexamination Certificate

active

07402688

ABSTRACT:
A novel 2,2-di-substituted 19-norvitamin D derivative. It is a compound represented by the general formula (I) wherein R1 and R2 are the same or different and each represents hydroxy and A represents hydrogen, or an unsubstituted linear or branched alkyl.

REFERENCES:
patent: 6566352 (2003-05-01), DeLuca et al.
patent: 6627622 (2003-09-01), DeLuca et al.
patent: 0619306 (1994-10-01), None
patent: WO 01/07405 (2001-02-01), None
patent: WO 01/74765 (2001-10-01), None
patent: WO 01/74766 (2001-10-01), None
patent: WO 01/92221 (2001-12-01), None
Shimizu, Masato et al. (DN 142:392562, CAPLUS, abstract of Bioorganic & Medicinal Chemistry Letters (2005), 15(5), 1451-1455).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin D... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin D..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin D... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2766341

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.